Revelation Biosciences, Inc. (NASDAQ: REVB) has announced that it successfully held a Special Meeting of Stockholders on March 18, 2026, where stockholders approved the issuance of shares related to Class J Common Stock Warrants. This approval is significant as it allows the company to issue shares that may exceed 20% of its total outstanding shares, which is a requirement under Nasdaq rules. The expiration date for these warrants has been set to March 18, 2031, following the stockholder approval. The meeting saw a quorum with 4,171,735 shares represented, which is more than one-third of the total shares entitled to vote. The approval of the warrants is expected to provide the company with additional liquidity and flexibility in its capital structure, potentially enhancing its operational capabilities and strategic initiatives moving forward.

Press Release distribution

National Press Distribution across U.S. Media. Direct Access to Key Decision Making Editors.